Exome sequencing of germline DNA from non-BRCA1/2 familial breast cancer cases selected on the basis of aCGH tumor profiling.
The bulk of familial breast cancer risk (∼70%) cannot be explained by mutations in the known predisposition genes, primarily BRCA1 and BRCA2. Underlying genetic heterogeneity in these cases is the probable explanation for the failure of all attempts to identify further high-risk alleles. While exome...
Guardado en:
Autores principales: | Florentine S Hilbers, Caro M Meijers, Jeroen F J Laros, Michiel van Galen, Nicoline Hoogerbrugge, Hans F A Vasen, Petra M Nederlof, Juul T Wijnen, Christi J van Asperen, Peter Devilee |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/4a061793332a4654a5c0029d77135335 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Genome-wide high-resolution aCGH analysis of gestational choriocarcinomas.
por: Henriette Poaty, et al.
Publicado: (2012) -
Comparison of the diagnostic yield of aCGH and genome-wide sequencing across different neurodevelopmental disorders
por: Francisco Martinez-Granero, et al.
Publicado: (2021) -
Correspondence of aCGH and long-read genome assembly for detection of copy number differences: A proof-of-concept with cichlid genomes.
por: Gabriel A Preising, et al.
Publicado: (2021) -
True 3q chromosomal amplification in squamous cell lung carcinoma by FISH and aCGH molecular analysis: impact on targeted drugs.
por: Matteo Brunelli, et al.
Publicado: (2012) -
Chromosomal minimal critical regions in therapy-related leukemia appear different from those of de novo leukemia by high-resolution aCGH.
por: Nathalie Itzhar, et al.
Publicado: (2011)